Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
50.04
+0.38 (0.77%)
Dec 5, 2025, 4:00 PM EST - Market closed
Hinge Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 534.39 | 390.4 | 292.73 |
| Revenue Growth (YoY) | 82.55% | 33.37% | - |
| Cost of Revenue | 113.17 | 89.81 | 98.55 |
| Gross Profit | 421.22 | 300.59 | 194.18 |
| Selling, General & Admin | 611.81 | 227.54 | 214.64 |
| Research & Development | 354.4 | 97.49 | 110.06 |
| Operating Expenses | 967.14 | 325.02 | 324.69 |
| Operating Income | -545.93 | -24.43 | -130.51 |
| Interest & Investment Income | 19.1 | 20.57 | 21.7 |
| Other Non Operating Income (Expenses) | 0.3 | 0.08 | 0.27 |
| EBT Excluding Unusual Items | -526.53 | -3.78 | -108.55 |
| Merger & Restructuring Charges | -6.79 | -7.48 | - |
| Pretax Income | -533.32 | -11.26 | -108.55 |
| Income Tax Expense | -0.08 | 0.68 | -0.41 |
| Net Income | -533.24 | -11.93 | -108.14 |
| Net Income to Common | -429.07 | -11.93 | -108.14 |
| Shares Outstanding (Basic) | 38 | 14 | 13 |
| Shares Outstanding (Diluted) | 38 | 14 | 13 |
| Shares Change (YoY) | 192.34% | 4.16% | - |
| EPS (Basic) | -11.28 | -0.88 | -8.31 |
| EPS (Diluted) | -11.28 | -0.88 | -8.31 |
| Free Cash Flow | 145.43 | 47.96 | -65.89 |
| Free Cash Flow Per Share | 3.82 | 3.54 | -5.06 |
| Gross Margin | 78.82% | 77.00% | 66.33% |
| Operating Margin | -102.16% | -6.26% | -44.59% |
| Profit Margin | -80.29% | -3.06% | -36.94% |
| Free Cash Flow Margin | 27.21% | 12.29% | -22.51% |
| EBITDA | -543.75 | -22.08 | -128.39 |
| EBITDA Margin | -101.75% | -5.66% | -43.86% |
| D&A For EBITDA | 2.18 | 2.35 | 2.13 |
| EBIT | -545.93 | -24.43 | -130.51 |
| EBIT Margin | -102.16% | -6.26% | -44.59% |
| Advertising Expenses | - | 37.3 | 23.8 |
Source: S&P Capital IQ. Standard template.
Financial Sources.